The official blog of the Lung Institute.

Do You Have Overlap Syndrome?

21 Aug 2014
| Under COPD, Lung Disease, Related Conditions | Posted by | 0 Comments
overlap syndrome Lung Institute

Overlap syndrome is considered to be relatively new to medicine. As you might have expected, the term refers to diseases that overlap one another so that the combined effect of multiple diseases or conditions are worse than either one alone. Currently, there are many examples of overlap syndrome in the medicine field, especially with auto-immune diseases such as lupus and arthritis.

But did you know that people who have chronic obstructive pulmonary disease (COPD) might be experiencing overlap syndrome? With more studies available, researchers have found that COPD patients could be suffering from more than severe COPD symptoms. What does overlap syndrome have to do with COPD? Do you have it?

COPD and Overlap Syndrome

COPD, as you may know, is a progressive form of lung disease that includes emphysema and chronic bronchitis. Symptoms include ongoing coughing, increased mucus, shortness of breath, fatigue and wheezing. Approximately 24 million Americans are living with COPD, but only half of them have been diagnosed with the condition. This means that a number of people are living with these severe symptoms and sudden flare-ups periodically. But what if you just didn’t have COPD?

One example of overlap syndrome involves COPD and obstructive sleep apnea (OSA). OSA is a sleep disorder defined as the unconscious stoppage of breathing for short periods of time throughout a night’s sleep. COPD and OSA can present the same symptoms, which makes overlap syndrome that much harder to discover and properly diagnose. This condition occurs in 10-15 percent of COPD patients, and is associated with reduced blood oxygen levels during sleep. Some studies have found that people with overlap syndrome have an increased risk of respiratory failure and pulmonary hypertension than individuals with just OSA or COPD alone.

More recently, overlap syndrome has been found involving both COPD and asthma. Asthma is a chronic lung disease that inflames and narrows the airways within the body. Asthma-COPD overlap syndrome (ACOS) shares many of the same characteristics of both conditions—shortness of breath, coughing and wheezing being similar symptoms—which doctors have recently started to research. Of course, more time is needed to study this form of overlap syndrome.

Diagnosing overlap syndrome can provide helpful information that may help direct treatment for other underlying conditions. COPD patients who have symptoms of other conditions should talk to their doctor about the potential for overlap syndrome.  If you or a loved one is interested in stem cell therapy for lung disease, then contact us at the Lung Institute to learn more or call (800) 729-3065 today.



* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.